Revascular Bio logo
VerifiedPharmaceutical Manufacturing· Founded 2022

Revascular Bio

We have developed the world's first discovery of vascular-specific stem cells as cell therapy, providing groundbreaking solutions for the patients suffering from unresolved microvascular diseases. Our patented seed technology, vascular endothelial stem cells, is distributed in blood vessels throughout the body and is essential for the maintenance and regeneration of blood vessels in the body. We provide novel solutions for many microvascular diseases through two therapeutic concepts. The first is angiogenesis therapy, which can be applied to digital ulcers of systemic sclerosis, diabetic wounds, critical limb ischemia, vascular dementia, breast reconstruction, etc. The second, with angiocrine therapy, it is possible to completely cure hemophilia and lysosomal storage disorder through cell transplantation.

7-day free trial · no credit card

HeadquartersSuita-Shi, JapanEmployees2(1 to 10)Founded year2022Websiterevascularbio.comLinkedIn profileLinkedIn

Verified contacts

1

available on Kipplo

LinkedIn employees

2

1 to 10 range

Open roles

no listings

Distinct roles

1

indexed titles

Tech stack

1

tools in use

Monthly traffic

organic / mo

Sign up free to see all 1 verified contacts at Revascular Bio

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up free

Decision-makers and verified team members

1 contacts with verified email or phone · masked until revealed.

Sign up free →

Showing 1 of 1 verified contacts

Top roles at Revascular Bio

1 distinct titles indexed · top 1 shown.

  • 1ceo

Sign up to unlock all 1 contacts at Revascular Bio

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up free

Sign up to reveal 1 verified contacts at Revascular Bio

7-day trial · no credit card · cancel anytime · only pay for verified records.

Trusted by sales, marketing, and GTM engineering teams.

Revascular Bio | Kipplo Discover